Salem Investment Counselors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Salem Investment Counselors's RGEN Position: Q1 2024 in Review
Salem Investment Counselors sold out of Repligen (RGEN) in Q1 2024, closing a stake of 30 shares — an estimated $5.39K sold.
Salem Investment Counselors first reported a position in RGEN in Q2 2023 and held it in 3 quarters. The position peaked at $5.39K in Q4 2023. 487 funds tracked by Wall St. Rank hold RGEN as of Q1 2024.
- Salem Investment Counselors reported no remaining Repligen position as of Q1 2024 after selling out during the quarter.
- Salem Investment Counselors sold 30 Repligen shares in Q1 2024, an estimated $5.39K.
- Salem Investment Counselors first reported a position in Repligen in Q2 2023 and held it in 3 quarters.
- Salem Investment Counselors's Repligen position peaked at $5.39K in Q4 2023.
- 487 funds tracked by Wall St. Rank held Repligen as of Q1 2024.
Based on Salem Investment Counselors's 13F filing for Q1 2024, filed 11 Apr 2024.